NATtrol Chlamydia Trachomatis serotype D, External Run Control, Low

NATtrol Chlamydia trachomatis External Run Controls (NATCT(D-UW3)-ERCL and NATCT(D-UW3)-ERCM) are formulated with purified, intact bacterial cells that have been chemically modified to render them non-infectious and refrigerator stable. Each control pack contains 6 x 1.0 mL vials of C. trachomatis NATtrol at target concentrations listed in Table 1. These controls are supplied in a purified protein matrix that mimics the composition of a true clinical specimen.

NATtrol Chlamydia trachomatis External Run Controls are designed to evaluate the performance of nucleic acid tests for determination of the presence of C. trachomatis DNA. NATCT(D-UW3)ERCL and NATCT(D-UW3)-ERCM can also be used for validation of clinical assays, development of diagnostic tests and training of laboratory personnel. NATCT(D-UW3)-ERCL and NATCT(D-UW3)-ERCM contain intact organisms and should be run in a manner identical to that used for clinical specimens.

Roche Cobas Ampliprep-Taqman ; Test : CT/NG / +2° to +8° C.
Product Insert.pdf

Material Safety Data Sheet.pdf